SYNOPSIS Levels of IgG, IgA, IgM, the total haemolytic complement (CH50), and the individual components Clq, C3, C4, C6, and C7 were measured in 29 pleural effusions. Of these, 18 were associated with carcinoma of the bronchus and 11 were non-malignant effusions including empyemas.
The level of IgG was significantly lower in the malignant group when compared with nonmalignant effusions. The usefulness of measurements of IgG with respect to malignant effusions associated with carcinoma of the bronchus requires an expanded study to show whether it has any real diagnostic value. There were no significant differences in other immunoglobulins, the CH50, and individual complement components between the two groups.
The identification of total haemolytic activity in the majority of effusions in both groups indicates that all nine components of the classical pathway of complement, including macromolecules such as Cl, can be present in pleural fluids.
There have been relatively few reports on measurements of immunoglobulins and complement in pleural fluid . Hunder et al (1972) found that the total haemolytic complement (CH5o), C4, and C3 concentrations were lower in the pleural fluids from patients with rheumatoid arthritis and systemic lupus erythematosus than in fluids from patients with malignant and other diseases. Hirsch et al (1971) reported the presence of immunoglobulins IgG, IgA, and IgM in nine pleural fluids in amounts comparable to those concentrations present in the serum.
Since there have been a number of reports which suggest that cancer patients have circulating antigenantibody complexes which in turn may lead to activation of complement, we have measured immunoglobulins and individual complement components in 18 malignant pleural fluids and compared these with 11 non-malignant effusions, including empyemas.
Material and methods

PLEURAL EFFUSIONS
Samples were centrifuged at 1500 g to remove partiReceived for publication 3 March 1976 culate matter, divided into portions, and kept at -80°C. The effusions were processed and stored on the same day as the pleural aspiration and were thawed only once before each assay.
TOTAL PROTEIN
This was measured by a standard AutoAnalyzer (Technicon Instruments Corporation Ltd, Basingstoke) method (Nl4b) which uses the biuret reaction. The between-batch precision (± 1 SD) was I 0 g/l.
IgG, IgA, AND IgM These were measured by an automated nephelometric procedure on an AutoAnalyzer If (method no. 12). The method incorporates 4 % polyethylene glycol in the antiserum diluent. Samples were prediluted manually (1:50 for IgA and IgM, and 1:200 for IgG) rather than on the AutoAnalyzer.
The between-batch precision (± 1 SD) in the range up to 300 IU/ml was 8-0 IU/ml for IgG, 12-6 IU/mi for IgA, and 7T0 IU/ml for IgM.
COMPLEMENT
The haemolytic complement (CH5o) was mcasured by the method of Mayer (1961) . Levels of complement components Clq and C3 were measured by single radial diffusion using monospecific antisera A. B. Kay, A. F. Smith, C. R. McGavin, and Susan B. Tuft raised in the rabbit. Levels of C4 and C6 wer measured using C4-deficient guinea-pig and C6 deficient rabbit sera respectively (Lachmann et a 1973) , and C7 was measured by the reactive lysi method (Thompson and Lachmann, 1970) . Immu noelectrophoresis was performed as describe (Scheidegger, 1955 ) using a rabbit antiserum t4 human plasma proteins purchased from Wellcom Reagents Ltd.
Results
When the electrophoretic pattern of malignant ani non-malignant pleural effusion, including empyema& was compared to the pattern of normal serum ther were no major differences in the number of position of the principal protein bands.
The amount of Ig Gper milligram total protein i the malignant effusions was significantly (p < 0 0l lower than the IgG content of the nonmalignan group (fig 1) . The differences in IgA and IgM pe milligram of total protein and in total protein cor centration itself between the two groups were nc significant. Total haemolytic complement was measurable i the majority of pleural effusions but there was n significant difference in levels between the malij nant and nonmalignant fluids (fig 2) . The individue components Clq, C4, C3, C6, and C7 were als detectable in the majority of effusions but no sip nificant differences were found between the tw groups ( fig 2) .
Discussion
In the report by Hirsch et al (1971) The reasons for the lower concentration of IgG in the malignant group is unknown. One explanation is that IgG is an inadvertent substrate for plasmin as a result of local fibrin formation and activation of he the fibrinolytic pathway. Disseminated intravascular th coagulation (DIC) in association with disseminated carcinoma is well recognized. Although DIC was not a complication in any of the patients studied here it is possible that there was low-grade conversion of plasminogen by a plasminogen activator in the pleural space of the patients with carcinoma. Levels of fibrin degradation products were higher in pleural fluids from patients with carcinoma than in nonmalignant fluids (J. D. Cash, personal communication).
Although we did not have the opportunity to measure plasma concentrations of immunoglobulins at the time of pleural aspirations, it is unlikely that our findings merely reflect low circulating IgG levels. In a report by Hughes (1971) IgG levels in cancer patients, including those with bronchogenic carcinoma, were significantly increased when compared with those in matched controls.
Measurements of the CH5o and individual components in body fluids other than plasma have been of value diagnostically. The complement levels in joint effusions in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) have been found to be lower than in 'non-rheumatoid' arthritis fluids from patients with osteoarthritis or gout (Pekin and Zvaifler, 1964; Franco and Schur, 1971) .
Similarly, the CH5o, Clq, C3, and C4 were lower in pleural fluids secondary to SLE and RA than in malignant pleural effusions (Hunder et al, 1972) . These findings are thought to be a consequence of complement activation by antigen-antibody complexes. Since there is evidence in both man and experimental animals for the presence of immune complexes in cancer (Baldwin et al, 1974) , in this study we have measured complement in malignant effusions and have included the terminal components C6 and C7. We have compared our malignant group with exudates associated with pneumonia, tuberculosis, and pulmonary infarction and with empyemas. Although we found no significant difference between our two groups in terms of complement measurements (fig 2) , the observation that many of these components were present adds to knowledge of the composition of pleural fluids.
The mechanism by which fluid accumulates within the pleural cavity is incompletely understood. Leckie and Tothill (1965) found that radiolabelled albumin can diffuse freely out of the pleural space, and it seems likely that most proteins in pleural effusions derive from the circulation as a result of the inflammatory process rather than from local production. It is reasonable to suppose that macromolecules, such as Cl (molecular size 900 000), can diffuse into the pleura. The majority of fluids from the malignant and nonmalignant groups had total complement activity (the CHso) which requires Cl and the other components of the 'classical pathway'.
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